The CMP testing market is fueled by increasing awareness of preventive healthcare and early detection of metabolic disorders. Chronic conditions such as diabetes, kidney diseases, and liver ailments, ...
ROSTOCK and BERLIN, GERMANY / ACCESSWIRE / April 10, 2019 / CENTOGENE today announced the launch of CentoMetabolic TM, a first-line test for the widest range of rare genetic metabolic diseases. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback